User:Mr. Ibrahem/Avatrombopag

Avatrombopag, sold under the brand name Doptelet, is a medication used to treat low platelets in chronic liver disease when an invasive medical procedure is required. It is taken by mouth.

Common side effects include fever, abdominal pain, nausea, headache, tiredness, and peripheral swelling. Other side effects may include blood clots. Use in pregnancy may harm the baby. Safety in pregnancy or breastfeeding is unclear. It is a thrombopoietin receptor agonist, which increases platelet production.

Avatrombopag was approved for medical use in the United States in 2018 and Europe in 2019. In the United Kingdom a course of treatment costs the NHS £640 to £960 as of 2020. In the United States this amount is 3,650 USD to 5,500 USD.